Melvin P. Weinstein
Impact in
- Clinical Biochemistry top 0.01%
- Bacterial Identification and Susceptibility Testing
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
Papers in
-
- Bacterial Identification and Susceptibility Testing 101
- Epidemiology 56
- Infective Endocarditis Diagnosis and Management 20
- Co-authors
- Clinical (1 shared paper)L. Barth Reller (61 shared papers)S Mirrett (38 shared papers)L G Reimer (17 shared papers)Michael L. Wilson (19 shared papers)Kenneth Lichtenstein (2 shared papers)James S. Lewis (3 shared papers)James R. Murphy (2 shared papers)
- Journals
- Journal of Clinical Microbiology (58 papers)Clinical Infectious Diseases (22 papers)Diagnostic Microbiology and Infectious Disease (12 papers)Antimicrobial Agents and Chemotherapy (7 papers)The American Journal of Medicine (5 papers)
- Partner nations
- United StatesGermanyDenmark
In The Last Decade
Melvin P. Weinstein
154 papers receiving 12.9k citations
Melvin P. Weinstein's Hit Papers
Peers
Comparison fields: 5 of 169
- Clinical Biochemistry 5.5k
- Applied Microbiology and Biotechnology 1.2k
- Molecular Medicine 2.8k
- Endocrinology 1.4k
- Infectious Diseases 3.5k
Countries citing papers authored by Melvin P. Weinstein
This map shows the geographic impact of Melvin P. Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin P. Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin P. Weinstein more than expected).
Fields of papers citing papers by Melvin P. Weinstein
This network shows the impact of papers produced by Melvin P. Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin P. Weinstein. The network helps show where Melvin P. Weinstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Melvin P. Weinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Performance standards for antimicrobial susceptibility testing Hit paper breakdown → | 2019 | 3057 |
| 2 | The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults Hit paper breakdown → | 1997 | 965 |
| 3 | The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations Hit paper breakdown → | 1983 | 609 |
| 4 | A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a Hit paper breakdown → | 2013 | 392 |
| 5 | 1983 | 386 | |
| 6 | 2007 | 354 | |
| 7 | The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes Hit paper breakdown → | 2020 | 352 |
| 8 | A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya Hit paper breakdown → | 2018 | 350 |
| 9 | A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya Hit paper breakdown → | 2018 | 323 |
| 10 | 1997 | 316 | |
| 11 | 2003 | 277 | |
| 12 | 1999 | 263 | |
| 13 | 2007 | 237 | |
| 14 | 1996 | 230 | |
| 15 | 2010 | 204 | |
| 16 | 2015 | 194 | |
| 17 | 1990 | 167 | |
| 18 | 2020 | 166 | |
| 19 | 1978 | 165 | |
| 20 | 2019 | 159 |
About Melvin P. Weinstein
Melvin P. Weinstein is a scholar working on Clinical Biochemistry, Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health and Statistics, Probability and Uncertainty, having authored 155 papers that have together received 13.5k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (101 papers), Streptococcal Infections and Treatments (39 papers), Antimicrobial Resistance in Staphylococcus (27 papers), Infective Endocarditis Diagnosis and Management (20 papers), Meta-analysis and systematic reviews (19 papers), Antibiotic Use and Resistance (18 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antibiotic Resistance in Bacteria (15 papers). The work is most often cited by research in Clinical Biochemistry (5.5k citations), Applied Microbiology and Biotechnology (1.2k citations), Molecular Medicine (2.8k citations), Endocrinology (1.4k citations) and Infectious Diseases (3.5k citations). Melvin P. Weinstein has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Clinical, L. Barth Reller, S Mirrett, L G Reimer, Michael L. Wilson, Kenneth Lichtenstein, James S. Lewis, James R. Murphy, Giovanni Parmigiani and Michael Towns. Their work appears in journals such as Journal of Clinical Microbiology, Clinical Infectious Diseases, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.